INVESTORS

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Achillion Reports Second Quarter 2016 Financial Results
NEW HAVEN, Conn. , Aug. 04, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and six months ended June 30, 2016. For the second quarter of 2016, Achillion reported a net loss of $18.5 million or $0.14 per share, compared with a
View HTML